Astraazin Pharmaceuticals

Pharmaceutical manufacturing and medicinal product services in India.

About Astraazin Pharmaceuticals

Astraazin Pharmaceuticals is a Healthcare company. Pharmaceutical manufacturing and medicinal product services in India. The company has 30 employees. Its Indian entity Astraazin Pharmaceuticals Private Limited reported revenue of β‚Ή4.00 Cr. Astraazin Pharmaceuticals offers products and services including Alexit-M and Hempack. Its focus areas include Contract Manufacturing, CRAMS Services, Outsourcing and Development and Pharmaceuticals.

Company details

Astraazin Pharmaceuticals was established in 2000 with core values such as integrity and excellence, starting from a small capital and a team of 10 employees. It has grown into a fast-expanding company offering a wide range of medicinal products globally, focusing on affordability and quality through contract manufacturing and research services. Operations are managed from locations in India, emphasizing innovation in fixed-dose combinations and accessibility of medicines, while contributing to societal and environmental concerns.

Key Metrics
  • Indian entity revenue
    ₹4.00 Cr

    FY 2025 · -6% YoY

  • Indian entity net profit
    ₹9.6 Lakh

    FY 2025 · 2% margin

  • Indian entity EBITDA
    ₹14.5 Lakh

    FY 2025 · 4% margin

  • Employee Count
    30

Products & Services of Astraazin Pharmaceuticals

Astraazin Pharmaceuticals offers a comprehensive portfolio of products and services, including Alexit-M and Hempack.

Alexit-M
Medicinal Products

A pharmaceutical product is manufactured for health-related applications.

Hempack
Medicinal Products

Another pharmaceutical product is developed for specific medicinal uses.

Board of directors of Astraazin Pharmaceuticals Private Limited (Astraazin Pharmaceuticals)

Astraazin Pharmaceuticals Private Limited is the primary company behind Astraazin Pharmaceuticals. The board of Astraazin Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Seerat Riyaz, appointed in 2014.

DirectorDesignationAppointedTenureEntity
Seerat Riyaz
DIN 06825011
Director08 Aug 201412 yrs 3 moAstraazin Pharmaceuticals Private Limited
Riyaz Ahmad Wani
DIN 02508923
Managing Director08 Aug 201412 yrs 3 moAstraazin Pharmaceuticals Private Limited

Financials of Astraazin Pharmaceuticals

Figures of Astraazin Pharmaceuticals Private Limited, the primary company behind Astraazin Pharmaceuticals, for FY 2025. Revenue was ₹4.00 Cr (-6% year on year). Net profit was ₹9.6 Lakh (2% margin). EBITDA was ₹14.5 Lakh (4% margin). Revenue has grown at a compounded annual rate of +3% over three years and 0% over five years.

  • ₹4.00 CrRevenue · FY 2025 · -6% YoY
  • ₹9.6 LakhNet profit · 2% margin
  • ₹14.5 LakhEBITDA · 4% margin
  • ₹1 LakhPaid-up capital
  • 30Employees (provident fund records)
  • +3%Revenue CAGR, 3 years
  • 0%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Astraazin Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Astraazin Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Astraazin Pharmaceuticals

Astraazin Pharmaceuticals has 30 employees.

The primary company behind Astraazin Pharmaceuticals, Astraazin Pharmaceuticals Private Limited, reported revenue of β‚Ή4.00 Cr for FY 2025, down 6% year on year.

Astraazin Pharmaceuticals was established in 2000 with core values such as integrity and excellence, starting from a small capital and a team of 10 employees. It has grown into a fast-expanding company offering a wide range of medicinal products globally, focusing on affordability and quality through contract manufacturing and research services. Operations are managed from locations in India, emphasizing innovation in fixed-dose combinations and accessibility of medicines, while contributing to societal and environmental concerns.

Astraazin Pharmaceuticals offers Alexit-M and Hempack.

Astraazin Pharmaceuticals operates through Astraazin Pharmaceuticals Private Limited.

The legal entities of Astraazin Pharmaceuticals currently have 2 directors, including Seerat Riyaz, Riyaz Ahmad Wani.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available